Global Docetaxel for Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 118
Published Date: 19 Jun 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Docetaxel for Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Docetaxel for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Docetaxel for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Docetaxel for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Docetaxel for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Docetaxel for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Docetaxel for Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Docetaxel for Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aventis Pharma S.A., Sanofi, Accord Healthcare, AuroMedics Pharma and Fresenius Kabi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Docetaxel for Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
10mg/ml
20mg/ml
30mg/ml
Others
Market segment by Application
Hospital
Clinic
Major players covered
Aventis Pharma S.A.
Sanofi
Accord Healthcare
AuroMedics Pharma
Fresenius Kabi
GLS Pharma
Hikma
Hospira
Teikoku Pharma
QILU Pharmaceutical
Shenzhen Main Luck Pharmaceuticals
Cisen Pharmaceutical
Shanghai Acebright Pharmaceuticals
Jiangsu Hengrui Pharmaceuticals
Yangtze River Pharmaceutical
Jiangsu Chia Tai-Tianqing Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Docetaxel for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Docetaxel for Injection, with price, sales, revenue and global market share of Docetaxel for Injection from 2018 to 2023.
Chapter 3, the Docetaxel for Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Docetaxel for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Docetaxel for Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Docetaxel for Injection.
Chapter 14 and 15, to describe Docetaxel for Injection sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Docetaxel for Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Docetaxel for Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 10mg/ml
1.3.3 20mg/ml
1.3.4 30mg/ml
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Docetaxel for Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Docetaxel for Injection Market Size & Forecast
1.5.1 Global Docetaxel for Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Docetaxel for Injection Sales Quantity (2018-2029)
1.5.3 Global Docetaxel for Injection Average Price (2018-2029)
2.1 Aventis Pharma S.A.
2.1.1 Aventis Pharma S.A. Details
2.1.2 Aventis Pharma S.A. Major Business
2.1.3 Aventis Pharma S.A. Docetaxel for Injection Product and Services
2.1.4 Aventis Pharma S.A. Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Aventis Pharma S.A. Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Docetaxel for Injection Product and Services
2.2.4 Sanofi Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments/Updates
2.3 Accord Healthcare
2.3.1 Accord Healthcare Details
2.3.2 Accord Healthcare Major Business
2.3.3 Accord Healthcare Docetaxel for Injection Product and Services
2.3.4 Accord Healthcare Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Accord Healthcare Recent Developments/Updates
2.4 AuroMedics Pharma
2.4.1 AuroMedics Pharma Details
2.4.2 AuroMedics Pharma Major Business
2.4.3 AuroMedics Pharma Docetaxel for Injection Product and Services
2.4.4 AuroMedics Pharma Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AuroMedics Pharma Recent Developments/Updates
2.5 Fresenius Kabi
2.5.1 Fresenius Kabi Details
2.5.2 Fresenius Kabi Major Business
2.5.3 Fresenius Kabi Docetaxel for Injection Product and Services
2.5.4 Fresenius Kabi Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Fresenius Kabi Recent Developments/Updates
2.6 GLS Pharma
2.6.1 GLS Pharma Details
2.6.2 GLS Pharma Major Business
2.6.3 GLS Pharma Docetaxel for Injection Product and Services
2.6.4 GLS Pharma Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GLS Pharma Recent Developments/Updates
2.7 Hikma
2.7.1 Hikma Details
2.7.2 Hikma Major Business
2.7.3 Hikma Docetaxel for Injection Product and Services
2.7.4 Hikma Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hikma Recent Developments/Updates
2.8 Hospira
2.8.1 Hospira Details
2.8.2 Hospira Major Business
2.8.3 Hospira Docetaxel for Injection Product and Services
2.8.4 Hospira Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hospira Recent Developments/Updates
2.9 Teikoku Pharma
2.9.1 Teikoku Pharma Details
2.9.2 Teikoku Pharma Major Business
2.9.3 Teikoku Pharma Docetaxel for Injection Product and Services
2.9.4 Teikoku Pharma Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Teikoku Pharma Recent Developments/Updates
2.10 QILU Pharmaceutical
2.10.1 QILU Pharmaceutical Details
2.10.2 QILU Pharmaceutical Major Business
2.10.3 QILU Pharmaceutical Docetaxel for Injection Product and Services
2.10.4 QILU Pharmaceutical Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 QILU Pharmaceutical Recent Developments/Updates
2.11 Shenzhen Main Luck Pharmaceuticals
2.11.1 Shenzhen Main Luck Pharmaceuticals Details
2.11.2 Shenzhen Main Luck Pharmaceuticals Major Business
2.11.3 Shenzhen Main Luck Pharmaceuticals Docetaxel for Injection Product and Services
2.11.4 Shenzhen Main Luck Pharmaceuticals Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shenzhen Main Luck Pharmaceuticals Recent Developments/Updates
2.12 Cisen Pharmaceutical
2.12.1 Cisen Pharmaceutical Details
2.12.2 Cisen Pharmaceutical Major Business
2.12.3 Cisen Pharmaceutical Docetaxel for Injection Product and Services
2.12.4 Cisen Pharmaceutical Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Cisen Pharmaceutical Recent Developments/Updates
2.13 Shanghai Acebright Pharmaceuticals
2.13.1 Shanghai Acebright Pharmaceuticals Details
2.13.2 Shanghai Acebright Pharmaceuticals Major Business
2.13.3 Shanghai Acebright Pharmaceuticals Docetaxel for Injection Product and Services
2.13.4 Shanghai Acebright Pharmaceuticals Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Shanghai Acebright Pharmaceuticals Recent Developments/Updates
2.14 Jiangsu Hengrui Pharmaceuticals
2.14.1 Jiangsu Hengrui Pharmaceuticals Details
2.14.2 Jiangsu Hengrui Pharmaceuticals Major Business
2.14.3 Jiangsu Hengrui Pharmaceuticals Docetaxel for Injection Product and Services
2.14.4 Jiangsu Hengrui Pharmaceuticals Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
2.15 Yangtze River Pharmaceutical
2.15.1 Yangtze River Pharmaceutical Details
2.15.2 Yangtze River Pharmaceutical Major Business
2.15.3 Yangtze River Pharmaceutical Docetaxel for Injection Product and Services
2.15.4 Yangtze River Pharmaceutical Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Yangtze River Pharmaceutical Recent Developments/Updates
2.16 Jiangsu Chia Tai-Tianqing Pharmaceutical
2.16.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Details
2.16.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
2.16.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Docetaxel for Injection Product and Services
2.16.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Docetaxel for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
3.1 Global Docetaxel for Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Docetaxel for Injection Revenue by Manufacturer (2018-2023)
3.3 Global Docetaxel for Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Docetaxel for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Docetaxel for Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Docetaxel for Injection Manufacturer Market Share in 2022
3.5 Docetaxel for Injection Market: Overall Company Footprint Analysis
3.5.1 Docetaxel for Injection Market: Region Footprint
3.5.2 Docetaxel for Injection Market: Company Product Type Footprint
3.5.3 Docetaxel for Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Docetaxel for Injection Market Size by Region
4.1.1 Global Docetaxel for Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Docetaxel for Injection Consumption Value by Region (2018-2029)
4.1.3 Global Docetaxel for Injection Average Price by Region (2018-2029)
4.2 North America Docetaxel for Injection Consumption Value (2018-2029)
4.3 Europe Docetaxel for Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Docetaxel for Injection Consumption Value (2018-2029)
4.5 South America Docetaxel for Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Docetaxel for Injection Consumption Value (2018-2029)
5.1 Global Docetaxel for Injection Sales Quantity by Type (2018-2029)
5.2 Global Docetaxel for Injection Consumption Value by Type (2018-2029)
5.3 Global Docetaxel for Injection Average Price by Type (2018-2029)
6.1 Global Docetaxel for Injection Sales Quantity by Application (2018-2029)
6.2 Global Docetaxel for Injection Consumption Value by Application (2018-2029)
6.3 Global Docetaxel for Injection Average Price by Application (2018-2029)
7.1 North America Docetaxel for Injection Sales Quantity by Type (2018-2029)
7.2 North America Docetaxel for Injection Sales Quantity by Application (2018-2029)
7.3 North America Docetaxel for Injection Market Size by Country
7.3.1 North America Docetaxel for Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Docetaxel for Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8.1 Europe Docetaxel for Injection Sales Quantity by Type (2018-2029)
8.2 Europe Docetaxel for Injection Sales Quantity by Application (2018-2029)
8.3 Europe Docetaxel for Injection Market Size by Country
8.3.1 Europe Docetaxel for Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Docetaxel for Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9.1 Asia-Pacific Docetaxel for Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Docetaxel for Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Docetaxel for Injection Market Size by Region
9.3.1 Asia-Pacific Docetaxel for Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Docetaxel for Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10.1 South America Docetaxel for Injection Sales Quantity by Type (2018-2029)
10.2 South America Docetaxel for Injection Sales Quantity by Application (2018-2029)
10.3 South America Docetaxel for Injection Market Size by Country
10.3.1 South America Docetaxel for Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Docetaxel for Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11.1 Middle East & Africa Docetaxel for Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Docetaxel for Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Docetaxel for Injection Market Size by Country
11.3.1 Middle East & Africa Docetaxel for Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Docetaxel for Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12.1 Docetaxel for Injection Market Drivers
12.2 Docetaxel for Injection Market Restraints
12.3 Docetaxel for Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13.1 Raw Material of Docetaxel for Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Docetaxel for Injection
13.3 Docetaxel for Injection Production Process
13.4 Docetaxel for Injection Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Docetaxel for Injection Typical Distributors
14.3 Docetaxel for Injection Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Docetaxel for Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Docetaxel for Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Aventis Pharma S.A. Basic Information, Manufacturing Base and Competitors
Table 4. Aventis Pharma S.A. Major Business
Table 5. Aventis Pharma S.A. Docetaxel for Injection Product and Services
Table 6. Aventis Pharma S.A. Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Aventis Pharma S.A. Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Docetaxel for Injection Product and Services
Table 11. Sanofi Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Recent Developments/Updates
Table 13. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 14. Accord Healthcare Major Business
Table 15. Accord Healthcare Docetaxel for Injection Product and Services
Table 16. Accord Healthcare Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Accord Healthcare Recent Developments/Updates
Table 18. AuroMedics Pharma Basic Information, Manufacturing Base and Competitors
Table 19. AuroMedics Pharma Major Business
Table 20. AuroMedics Pharma Docetaxel for Injection Product and Services
Table 21. AuroMedics Pharma Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. AuroMedics Pharma Recent Developments/Updates
Table 23. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 24. Fresenius Kabi Major Business
Table 25. Fresenius Kabi Docetaxel for Injection Product and Services
Table 26. Fresenius Kabi Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Fresenius Kabi Recent Developments/Updates
Table 28. GLS Pharma Basic Information, Manufacturing Base and Competitors
Table 29. GLS Pharma Major Business
Table 30. GLS Pharma Docetaxel for Injection Product and Services
Table 31. GLS Pharma Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. GLS Pharma Recent Developments/Updates
Table 33. Hikma Basic Information, Manufacturing Base and Competitors
Table 34. Hikma Major Business
Table 35. Hikma Docetaxel for Injection Product and Services
Table 36. Hikma Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hikma Recent Developments/Updates
Table 38. Hospira Basic Information, Manufacturing Base and Competitors
Table 39. Hospira Major Business
Table 40. Hospira Docetaxel for Injection Product and Services
Table 41. Hospira Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hospira Recent Developments/Updates
Table 43. Teikoku Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Teikoku Pharma Major Business
Table 45. Teikoku Pharma Docetaxel for Injection Product and Services
Table 46. Teikoku Pharma Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Teikoku Pharma Recent Developments/Updates
Table 48. QILU Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. QILU Pharmaceutical Major Business
Table 50. QILU Pharmaceutical Docetaxel for Injection Product and Services
Table 51. QILU Pharmaceutical Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. QILU Pharmaceutical Recent Developments/Updates
Table 53. Shenzhen Main Luck Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Shenzhen Main Luck Pharmaceuticals Major Business
Table 55. Shenzhen Main Luck Pharmaceuticals Docetaxel for Injection Product and Services
Table 56. Shenzhen Main Luck Pharmaceuticals Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Shenzhen Main Luck Pharmaceuticals Recent Developments/Updates
Table 58. Cisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Cisen Pharmaceutical Major Business
Table 60. Cisen Pharmaceutical Docetaxel for Injection Product and Services
Table 61. Cisen Pharmaceutical Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Cisen Pharmaceutical Recent Developments/Updates
Table 63. Shanghai Acebright Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Shanghai Acebright Pharmaceuticals Major Business
Table 65. Shanghai Acebright Pharmaceuticals Docetaxel for Injection Product and Services
Table 66. Shanghai Acebright Pharmaceuticals Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Shanghai Acebright Pharmaceuticals Recent Developments/Updates
Table 68. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 69. Jiangsu Hengrui Pharmaceuticals Major Business
Table 70. Jiangsu Hengrui Pharmaceuticals Docetaxel for Injection Product and Services
Table 71. Jiangsu Hengrui Pharmaceuticals Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 73. Yangtze River Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Yangtze River Pharmaceutical Major Business
Table 75. Yangtze River Pharmaceutical Docetaxel for Injection Product and Services
Table 76. Yangtze River Pharmaceutical Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Yangtze River Pharmaceutical Recent Developments/Updates
Table 78. Jiangsu Chia Tai-Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
Table 80. Jiangsu Chia Tai-Tianqing Pharmaceutical Docetaxel for Injection Product and Services
Table 81. Jiangsu Chia Tai-Tianqing Pharmaceutical Docetaxel for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 83. Global Docetaxel for Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 84. Global Docetaxel for Injection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Docetaxel for Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 86. Market Position of Manufacturers in Docetaxel for Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Docetaxel for Injection Production Site of Key Manufacturer
Table 88. Docetaxel for Injection Market: Company Product Type Footprint
Table 89. Docetaxel for Injection Market: Company Product Application Footprint
Table 90. Docetaxel for Injection New Market Entrants and Barriers to Market Entry
Table 91. Docetaxel for Injection Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Docetaxel for Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 93. Global Docetaxel for Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 94. Global Docetaxel for Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Docetaxel for Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Docetaxel for Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 97. Global Docetaxel for Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 98. Global Docetaxel for Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Global Docetaxel for Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Global Docetaxel for Injection Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Docetaxel for Injection Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Docetaxel for Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 103. Global Docetaxel for Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 104. Global Docetaxel for Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Global Docetaxel for Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Global Docetaxel for Injection Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Docetaxel for Injection Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Docetaxel for Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 109. Global Docetaxel for Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 110. North America Docetaxel for Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 111. North America Docetaxel for Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 112. North America Docetaxel for Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 113. North America Docetaxel for Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 114. North America Docetaxel for Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 115. North America Docetaxel for Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 116. North America Docetaxel for Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Docetaxel for Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Docetaxel for Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Europe Docetaxel for Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Europe Docetaxel for Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 121. Europe Docetaxel for Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 122. Europe Docetaxel for Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 123. Europe Docetaxel for Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 124. Europe Docetaxel for Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Docetaxel for Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Docetaxel for Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 127. Asia-Pacific Docetaxel for Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 128. Asia-Pacific Docetaxel for Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 129. Asia-Pacific Docetaxel for Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 130. Asia-Pacific Docetaxel for Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 131. Asia-Pacific Docetaxel for Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 132. Asia-Pacific Docetaxel for Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Docetaxel for Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Docetaxel for Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 135. South America Docetaxel for Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 136. South America Docetaxel for Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 137. South America Docetaxel for Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 138. South America Docetaxel for Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 139. South America Docetaxel for Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 140. South America Docetaxel for Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Docetaxel for Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Docetaxel for Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 143. Middle East & Africa Docetaxel for Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 144. Middle East & Africa Docetaxel for Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 145. Middle East & Africa Docetaxel for Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 146. Middle East & Africa Docetaxel for Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 147. Middle East & Africa Docetaxel for Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 148. Middle East & Africa Docetaxel for Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Docetaxel for Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Docetaxel for Injection Raw Material
Table 151. Key Manufacturers of Docetaxel for Injection Raw Materials
Table 152. Docetaxel for Injection Typical Distributors
Table 153. Docetaxel for Injection Typical Customers
List of Figures
Figure 1. Docetaxel for Injection Picture
Figure 2. Global Docetaxel for Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Docetaxel for Injection Consumption Value Market Share by Type in 2022
Figure 4. 10mg/ml Examples
Figure 5. 20mg/ml Examples
Figure 6. 30mg/ml Examples
Figure 7. Others Examples
Figure 8. Global Docetaxel for Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Docetaxel for Injection Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Global Docetaxel for Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Docetaxel for Injection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Docetaxel for Injection Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Docetaxel for Injection Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Docetaxel for Injection Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Docetaxel for Injection Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Docetaxel for Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Docetaxel for Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Docetaxel for Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Docetaxel for Injection Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Docetaxel for Injection Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Docetaxel for Injection Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Docetaxel for Injection Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Docetaxel for Injection Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Docetaxel for Injection Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Docetaxel for Injection Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Docetaxel for Injection Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Docetaxel for Injection Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Docetaxel for Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Docetaxel for Injection Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Docetaxel for Injection Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Docetaxel for Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Docetaxel for Injection Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Docetaxel for Injection Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Docetaxel for Injection Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Docetaxel for Injection Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Docetaxel for Injection Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Docetaxel for Injection Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Docetaxel for Injection Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Docetaxel for Injection Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Docetaxel for Injection Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Docetaxel for Injection Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Docetaxel for Injection Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Docetaxel for Injection Consumption Value Market Share by Region (2018-2029)
Figure 54. China Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Docetaxel for Injection Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Docetaxel for Injection Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Docetaxel for Injection Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Docetaxel for Injection Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Docetaxel for Injection Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Docetaxel for Injection Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Docetaxel for Injection Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Docetaxel for Injection Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Docetaxel for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Docetaxel for Injection Market Drivers
Figure 75. Docetaxel for Injection Market Restraints
Figure 76. Docetaxel for Injection Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Docetaxel for Injection in 2022
Figure 79. Manufacturing Process Analysis of Docetaxel for Injection
Figure 80. Docetaxel for Injection Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Aventis Pharma S.A. Sanofi Accord Healthcare AuroMedics Pharma Fresenius Kabi GLS Pharma Hikma Hospira Teikoku Pharma QILU Pharmaceutical Shenzhen Main Luck Pharmaceuticals Cisen Pharmaceutical Shanghai Acebright Pharmaceuticals Jiangsu Hengrui Pharmaceuticals Yangtze River Pharmaceutical Jiangsu Chia Tai-Tianqing Pharmaceutical
Related Reports
19 Jun 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
